Silencing SIRT2, a Sirtuin Enzyme, Reduces Malignancy in Deadly Breast Cancer Subtype
Monday, October 31, 2016 - 09:31
in Health & Medicine
Silencing SIRT2, a member of the sirtuin family of enzymes, reduces the invasiveness of basal-like breast cancer cells in culture and inhibits tumor growth in mice, according to new research led by scientists from Tufts University School of Medicine.